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anatomically based largely in the hippocampus; and, (2) work-
ing memory/executive function, which is anatomically based in 
the prefrontal cortex (see Burke and Barnes, 2006). A complete 
description of the neurobiological substrates of these age-related 
memory deﬁ  cits have yet to be elucidated, but at least in the case 
of the hippocampus, certainly include aberrant changes in gene 
transcription that ultimately affect the ability of the aged brain to 
learn and remember (e.g. Blalock et al., 2003; Small et al., 2004; 
Rowe et al., 2007). Indeed, it has been well-established that memory 
and synaptic plasticity processes in the cognitively healthy adult 
require transcription of immediate-early genes (IEGs), including 
Arc (activity-regulated cytoskeletal gene), zif268 (also known as 
nerve growth factor inducible-A), and bdnf (brain-derived neu-
rotrophic factor) (Guzowski et al., 2000; Hall et al., 2000; French 
et al., 2001; Steward and Worley, 2001). Moreover, blocking the 
expression of these genes in adult animals prevents the consolida-
tion of memory (Linnarsson et al., 1997; Guzowski et al., 2000; 
French et al., 2001), and decreased IEG expression is prevalent in 
many models of memory disorders (Dickey et al., 2003; Palop et al., 
2005; Rosi et al., 2005) and a result of the normal aging process (e.g. 
Blalock et al., 2003; Small et al., 2004; Rowe et al., 2007).
The molecular mechanisms driving these changes in gene tran-
scription are not currently known, but recent work points to a 
potential novel mechanism, dysregulation of epigenetic mecha-
nisms. Waddington (1957) was the ﬁ  rst to use the term epigenetics 
to describe a mechanism or mechanisms that are ‘on top of’ or 
INTRODUCTION
Age-associated cognitive decline is an increasing biomedical concern 
in the US. According to the Administration on Aging, over 12% of the 
United States population is age 65 and older, and by 2030 this esti-
mate is projected to reach 20%. In the general ﬁ  eld of aging research, 
substantial effort has been focused on pathological aging associated 
with diseases such as Alzheimer’s disease. While this disease and many 
others are certainly devastating, it is also true that most people will 
not suffer from a dementing condition as they age; the prevalence of 
dementia among individuals aged 71 and older is 13.9% (Plassman 
et al., 2007). Instead, most individuals will develop milder cognitive 
deﬁ  cits known as age-associated memory impairment (AAMI; Crook 
et al., 1986; Crook and Ferris, 1992; Ferris and Kluger, 1996). The 
memory deﬁ  cits associated with AAMI are relatively subtle compared 
to those associated with a dementing condition, but they are nev-
ertheless troublesome for the affected individual and their families, 
negatively affecting quality of life. Thus, with the average life span 
increasing, understanding the brain mechanisms that underlie age-
associated memory decline is of increasing importance. The study 
of the mechanisms that contribute to age-related memory decline 
will not only lead to a better general understanding of memory func-
tion, but promises hope of more effective prevention strategies and 
improvement of the quality of life for our aging population.
Work in model systems ranging from rodents to humans indi-
cates that aging-related memory decline is manifest in at least two 
memory modalities: (1) declarative/episodic memory, which is 
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‘above’ the level of the genes encoded by the DNA sequence. These 
mechanisms, which can be inﬂ  uenced by environmental factors 
such as diet (e.g., Waterland and Jirtle, 2003) and experiential fac-
tors such as maternal care (e.g. Weaver et al., 2004), can ultimately 
control which genes will be expressed, and allow cells and even 
whole organisms with the same genome (e.g. identical twins, Fraga 
et al., 2005) to become phenotypically distinct. The traditional view 
has been that once epigenetic marks (discussed below) have been 
laid down during development, they remain unchanged for the 
life of the organism. Recent work in the adult organism, however, 
has challenged this view, and thus the term ‘epigenetics’ may need 
to be expanded to include additional possibilities (see Bird, 2007). 
For example, recent work (discussed in greater detail below) indi-
cates that epigenetic marks can be rapidly (within minutes) and 
transiently (less than 24 h) changed to dynamically regulate gene 
transcription in the adult brain (Miller and Sweatt, 2007). Our 
hypothesis is that this type of dynamic change is dysregulated in 
the aged brain, and contributes to cognitive impairments.
The relevant epigenetic mechanisms include DNA methylation 
and histone post-translational modiﬁ  cations, mechanisms that 
have recently been discovered to control hippocampal synaptic 
plasticity and long-term memory formation (Barrett and Wood, 
2008; Jiang et al., 2008). These epigenetic changes involve the cova-
lent chemical modiﬁ  cation of DNA by DNA methyltransferases 
(DNMTs), and histones by histone acetyltransferases (HATs) and 
histone deacetylases (HDACs). These epigenetic mechanisms are 
powerful controllers of memory-associated gene transcription, 
and in general result in transcriptional silencing and loss of gene 
function through DNA methylation or transcriptional activation 
by histone acetylation, although numerous other modiﬁ  cations 
and effects are possible (Chahrour et al., 2008; Suzuki and Bird, 
2008). Overall, it is now appreciated that DNA methylation plays 
a key role in dynamically regulating gene transcription in the 
adult CNS (Levenson et al., 2006; Miller and Sweatt, 2007; Lubin 
et al., 2008), in concert with histone acetylation (Levenson et al., 
2004; Lubin et al., 2008; Miller et al., 2008), and that these proc-
esses are integral in long-term memory formation. What is not 
currently known is whether alterations in these mechanisms play 
a key role in the age-related changes in gene transcription and 
memory decline.
This has led us to hypothesize that dysregulation of epige-
netic control mechanisms and aberrant epigenetic “marks” (i.e. 
the chemical additions to DNA and histone proteins) contribute 
to aging-related cognitive dysfunction. Speciﬁ   cally, given that 
the transcription of key memory-promoting genes are known to 
decline during aging (Blalock et al., 2003; Small et al., 2004; Rowe 
et al., 2007), we propose that these changes are regulated by aber-
rant epigenetic marks and control mechanisms within brain regions 
particularly vulnerable to the aging process, which together result in 
age-related cognitive deﬁ  cits. This is the central hypothesis exam-
ined in this review.
MEMORY AND GENE TRANSCRIPTION IN THE AGED BRAIN
MEMORY AND LTP IN THE AGED BRAIN
Spatial cognition involves the ability of an organism to acquire 
and retain information critical for successful navigation through 
space. An abundance of research indicates that this behavior is 
dependent on the hippocampus, since damage to this structure, 
and other closely related structures, impairs performance on tasks 
that measure spatial learning and memory including the Morris 
swim task (Morris et al., 1982), the 14-unit T-maze (Bresnahan 
et al., 1988), the Y-maze (Aggleton et al., 1986), the radial arm maze 
(Olton et al., 1978), and the circular platform task (McNaughton 
et al., 1989). Because the hippocampus is a brain region vulner-
able to the normal aging process, it perhaps is not surprising that 
performance on tasks that require information processing within 
this structure is impaired with age. In fact, age-related decline in 
navigational skills are well documented in humans (e.g. Allen et al., 
2004; Driscoll et al., 2005), and spatial memory deﬁ  cits appear 
in aged monkeys (Lai et al., 1995; Rapp et al., 1997), dogs (Head 
et al., 1995), rats (Gallagher and Rapp, 1997), and mice (Bach et al., 
1999). In rats, age-related spatial learning and memory deﬁ  cits 
have been consistently observed using the Barnes maze (Barnes, 
1979), the Morris swim task (e.g. Gage et al., 1984; Rapp et al., 
1987; Markowska et al., 1989; Barnes et al., 1997; Shen et al., 1997), 
the T-maze (e.g. Barnes et al., 1980), and the 8-arm radial maze 
(e.g. Barnes et al., 1980; de Toledo-Morrell et al., 1984). These deﬁ  -
cits often appear to mimic those observed in animals with direct 
lesions of the hippocampus, although the impairments observed 
in aged rats are less severe.
While it is certainly true that hippocampal-dependent memory 
is impaired in aged organisms, these impairments are not the result 
of massive cell death. In fact, with only a few exceptions, the hip-
pocampus remains relatively structurally intact in the aged mouse, 
rat, monkey and human undergoing normal aging (for review see 
Rosenzweig and Barnes, 2003; Burke and Barnes, 2006). In addi-
tion, most electrical properties remain constant over the lifespan 
(Barnes, 1994), including resting membrane potential, membrane 
time constant, input resistance, and threshold to reach an action 
potential (Barnes, 1979; Barnes and McNaughton, 1980; Segal, 
1982; Landﬁ  eld and Pitler, 1984; Niesen et al., 1988; Kerr et al., 
1989; Reynolds and Carlen, 1989; Pitler and Landﬁ  eld, 1990; Turner 
and Deupree, 1991; Barnes et al., 1992; Potier et al., 1992, 1993; 
Luebke and Rosene, 2003), although Ca2+ dysregulation is evident, 
including an increase in Ca2+ conductance, and increased density 
of L-type Ca2+ channels (Landﬁ  eld, 1988; Thibault and Landﬁ  eld, 
1996; Foster and Norris, 1997; Toescu et al., 2004). Despite the rela-
tive sparing of the electrical properties of the hippocampus, syn-
aptic plasticity mechanisms do change in the aged brain, including 
long-term potentiation (LTP), which is widely believed to represent 
an experimental analog of memory.
Most current theories regarding the cellular basis of learn-
ing and memory propose that information is stored via activity-
dependent changes at the synapse. Bliss and Lomo (1973) were the 
ﬁ  rst to describe a long-lasting increase in the strength of synaptic 
transmission within the hippocampus, a phenomenon that eventu-
ally became known as long-term potentiation (LTP; Douglas and 
Goddard, 1975). The delivery of brief, high frequency stimulation 
to the perforant path inputs into the dentate gyrus, resulted in a 
subsequent change in the amplitude of population excitatory post 
synaptic potentials (EPSPs) that lasted for several hours. Since this 
initial observation, there are literally thousands of papers reporting 
on various aspects of the LTP phenomenon. Thus, much of what 
we know about synaptic plasticity within the hippocampus has Frontiers in Aging Neuroscience  www.frontiersin.org  March  2010 | Volume  2 | Article  9 | 3
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come from studying the mechanisms of LTP induction (some-
times referred to as early-phase LTP) and maintenance (sometimes 
referred to late-phase LTP).
In the aged brain, when high-intensity stimulation protocols 
that are well above threshold for LTP induction are used, there are 
no age-related deﬁ  cits in LTP induction at the CA3-CA1 Schaffer 
collateral synapse (e.g., Landﬁ  eld and Lynch, 1977; Landﬁ  eld et al., 
1978) or the perforant-path-granule cell synapse (e.g., Barnes, 
1979). When, however, stimulus parameters are very close to the 
LTP induction threshold, aged rats consistently show LTP induction 
deﬁ  cits at the Schaffer collateral CA1 synapse and the perforant 
path-granule cell synapse (e.g., Deupree et al., 1993; Moore et al., 
1993; Barnes et al., 2000). After LTP has been induced, the main-
tenance of LTP can also be measured and divided into an ‘early 
phase’ lasting one to 3 h and a ‘late phase’ lasting for more than 24 h. 
Several studies have demonstrated that in the short-term (i.e., over 
1 h), LTP decay rates are not different between aged and young rats 
(e.g. Landﬁ  eld and Lynch, 1977; Landﬁ  eld et al., 1978), but over 
a longer time course, signiﬁ  cant age-related maintenance deﬁ  cits 
do appear (e.g. Barnes, 1979; Barnes and McNaughton, 1980; for 
review see Barnes, 2003). For example, Barnes and McNaughton 
(1980) administered LTP-inducing stimuli at 24-hour intervals on 
12 consecutive days, then monitored the evoked ﬁ  eld response for 
several weeks. Although there were no age-related differences in 
the ﬁ  nal levels of LTP induction, LTP decayed nearly twice as fast 
in the aged rats over several weeks.
Several experiments have also demonstrated a signiﬁ  cant cor-
relation between LTP and memory deﬁ  cits in aged animals (Barnes, 
1979; Barnes and McNaughton, 1980, 1985; de Toledo-Morrell and 
Morrell, 1985; Bach et al., 1999). This was ﬁ  rst demonstrated by 
Barnes (1979) who showed that aged rats took longer path lengths 
and a greater amount of time to solve a spatial memory task (i.e., the 
Barnes maze). These deﬁ  cits in spatial memory performance were 
signiﬁ  cantly correlated with the durability of synaptic enhancement 
in the dentate gyrus both within and between age groups. In sub-
sequent studies, Barnes et al. (1980) and Barnes and McNaughton 
(1985) also demonstrated a signiﬁ  cant correlation between the rates 
of acquisition and forgetting of spatial memory and the induction 
and maintenance of LTP. Aged rats were slower to reach asymp-
totic performance levels and forgot the problem faster than did 
young rats. Similarly, LTP was induced more slowly and decayed 
more rapidly in aged rats. In both cases, the rate of decay for the 
memory of the escape box and LTP was nearly twice as fast for the 
aged rats. Bach et al. (1999) also found a signiﬁ  cant relationship 
between LTP decay rates in area CA1 in vitro and performance on 
the Barnes maze in aged but not young mice. These ﬁ  ndings are 
further supported by observations that old animals with spatial 
memory deﬁ  cits on the 8-arm radial maze also show faster decay 
rates for hippocampal LTP (de Toledo-Morrell and Morrell, 1985). 
Taken together, the currently available data indicate that learning 
and memory deﬁ  cits observed in aged rats and mice parallel deﬁ  cits 
in the induction and maintenance of LTP.
GENE TRANSCRIPTION IN LEARNING AND MEMORY
Early work on the molecular mechanisms of memory highlighted 
the need for gene transcription and expression to support the 
maintenance of long-term memory (reviewed in Alberini, 2009). 
Operationally deﬁ  ned, IEGs are those genes whose transcription 
can be induced in the presence of protein synthesis inhibitors, and 
they represent the earliest genomic response to patterned synap-
tic activity (Guzowski, 2002). The intracellular events that trigger 
IEG transcription begin with NMDA receptor activation and the 
eventual translocation of ERK to the nucleus where it activates the 
transcription factors CREB and Elk-1 (Impey et al., 1998; Roberson 
et al., 1999), resulting in changes in IEG transcription. The putative 
cellular functions of this diverse group of genes (e.g. transcription 
factors, cellular growth, synaptic modiﬁ  cation/structural changes, 
synaptic homeostasis) make them excellent candidates for critical 
components of synaptic plasticity processes (reviewed in Lanahan 
and Worley, 1998). Evidence supporting a role for IEGs in memory 
function is abundant, although some particularly compelling evi-
dence exists for Arc, zif268 and bdnf. In the following section we will 
brieﬂ  y review some of the relevant background for these speciﬁ  c 
memory-associated target genes.
In many respects Arc is the prototypical rapidly induced memory-
associated gene in the CNS. Arc transcription is induced selectively 
in the principal cells of the hippocampus and other brain regions 
by neural activity speciﬁ  cally associated with active information 
processing that occurs in spatial learning and memory formation 
(Guzowski et al., 2005; Miyashita et al., 2008). When Arc expression 
is inhibited, there is no signiﬁ  cant effect on the induction of LTP, 
or on acquisition of the Morris swim task; however, there is inter-
ference with the maintenance of LTP over several days (Guzowski 
et al., 2000). Moreover, rats that had previously learned the location 
of the hidden platform on the Morris swim task, when treated to 
eliminate Arc expression 8 h after acquisition of the task, failed to 
recall the platform’s location upon later testing (Guzowski et al., 
2000). Experiments using Arc knockout mice have revealed similar 
effects on long-term spatial, taste, and fear memory (McIntyre et al., 
2005; Plath et al., 2006). Mechanistically, Arc plays a critical role in 
regulating AMPA receptor trafﬁ  cking (Chowdhury et al., 2006) and 
homeosynaptic scaling of synapses that contain AMPA receptors 
(Rial Verde et al., 2006; Shepherd et al., 2006), both of which are 
essential for efﬁ  cient and reliable synaptic plasticity (Malinow and 
Malenka, 2002; Bredt and Nicoll, 2003).
Zif268 functions as an inducible regulatory transcription factor, 
and it is known to regulate the transcription of at least 20 delayed-
response genes (reviewed in Knapska and Kaczmarek, 2004), and 
can therefore have a dramatic effect on long-term cellular function. 
Using a mutant mouse with a targeted disruption of zif268, Jones 
et al. (2001) addressed whether zif268 is required for the mainte-
nance of late LTP and for the expression of long-term memory. In 
this study, mutant mice exhibited early LTP in the dentate gyrus, 
but late LTP was absent when measured 24 and 48 h after tetanus. 
Further, on both spatial and non-spatial learning tasks, short-term 
memory remained intact in the mutant mice, but performance was 
impaired in tests requiring long-term memory. In addition, sub-
sequent work by Lee et al. (2004) suggests that zif268 is necessary 
for hippocampal memory re-consolidation, but not for the initial 
consolidation of a memory. Although the debate over memory 
consolidation and re-consolidation processes remains controver-
sial, (see Nader and Hardt, 2009), these results indicate that zif268 
is essential for the stabilization of long-term synaptic plasticity and 
for the expression of long-term memories.Frontiers in Aging Neuroscience  www.frontiersin.org  March  2010 | Volume  2 | Article  9 | 4
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Bdnf is also a prominent and powerful regulator of synaptic 
plasticity and memory formation. The rodent bdnf gene consists 
of nine 5′-exons linked to separate promoters and one 3-exon 
which codes for the mature bdnf protein (Liu et al., 2006; Aid 
et al., 2007; Pruunsild et al., 2007). Due to the complexity of the 
bdnf gene, at least 11 different bdnf transcripts can be generated 
from the mammalian rodent bdnf gene by alternative splicing 
(Pruunsild et al., 2007). The activation of different bdnf promot-
ers is brain-region-speciﬁ  c and depends on the type of stimu-
lus used (Metsis et al., 1993; Timmusk et al., 1993; Bishop et al., 
1994; Kokaia et al., 1994). An abundance of evidence supports 
the idea that bdnf is critical for learning-related synaptic plas-
ticity and the maintenance of long-term memory. For example, 
training on a hippocampus-dependent contextual learning task 
signiﬁ  cantly increases bdnf within the hippocampus (Hall et al., 
2000), and when endogenous bdnf is blocked, adult rats experi-
ence impairments in spatial learning and memory (Mu et al., 
1999; Heldt et al., 2007). In addition, the induction of LTP signiﬁ  -
cantly increases bdnf mRNA levels (Patterson et al., 1992; Castren 
et al., 1993), while LTP is impaired in mice that lack the bdnf gene 
(Korte et al., 1995, 1996).
If IEGs are necessary for synaptic plasticity and memory func-
tion, and these processes are altered in aged animals, then it would 
be predicted that the transcription of the IEGs necessary for nor-
mal synaptic plasticity and memory function are altered in the 
aged brain. In fact, decreased IEG expression does accompany 
the normal aging process. Large-scale microarray investigations 
have observed a signiﬁ  cant down-regulation of zif268, Arc, Narp 
and Homer1a in the hippocampus of memory-impaired aged rats 
(Blalock et al., 2003; Rowe et al., 2007). In regards to bdnf, a great 
deal of work indicates that this gene and its receptors undergo 
signiﬁ  cant age-associated down-regulation (reviewed in Tapia-
Arancibia et al., 2008). For example, Hattiangady et al. (2005) 
found that bdnf is down-regulated within area CA1, CA3 and 
the dentate gyrus in middle-aged and aged rats. Taken together, 
these studies indicate that several genes already known to be nec-
essary for synaptic plasticity and normal memory function are 
down-regulated within the aged brain, including Arc, zif268 and 
bdnf. What remains to be determined are the mechanisms that 
contribute to age-associated changes in gene transcription. We 
propose that age-related alterations in DNA methylation and his-
tone modiﬁ  cations lead to age-associated disruption of memory-
promoting gene transcription.
EPIGENETIC MECHANISMS IN MEMORY FORMATION
A ROLE FOR DNA METHYLATION IN MEMORY FUNCTION
DNA methylation and histone modiﬁ  cations are two of the most 
extensively investigated epigenetic mechanisms (Figure 1). Until 
recently, it was thought that once laid down, these epigenetic marks 
remained unchanged for the lifetime of the organism, but recent 
studies in the nervous system have challenged this view. It is now 
apparent that epigenetic marks can be modiﬁ  ed in response to an 
organism’s experience, and play a key role in dynamically regulating 
the gene transcription supporting synaptic plasticity and long-term 
memory formation (Levenson and Sweatt, 2005; Graff and Mansuy, 
2008; Jiang et al., 2008; Liu et al., 2009; Sweatt, 2009).
FIGURE 1 | Schematic representation of epigenetic mechanisms. (A) In the 
nucleus, DNA coils and condenses around histones. Each octameric histone 
core contains two copies each of histones H2A, H2B, H3, and H4. The 
DNA–protein complex is referred to as chromatin. (B) The DNA-histone 
interaction occurs at the N-terminal tail of a histone, where for example on the 
H3 N-terminal tail, there are several sites for epigenetic marking via acetylation, 
methylation, and phosphorylation. (C) In and around gene promoters that are 
rich in cytosine-guanine nucleotides (CpG islands), methyl groups are transferred 
to CpG sites. This process, called DNA methylation, is catalyzed by a class of 
enzymes known at DNA methyltransferases.Frontiers in Aging Neuroscience  www.frontiersin.org  March  2010 | Volume  2 | Article  9 | 5
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Much of the work devoted to testing the idea that epigenetic 
mechanisms regulate gene transcription necessary for memory 
function has focused on posttranslational histone modiﬁ  cations, 
especially histone acetylation (reviewed in Barrett and Wood, 
2008; Graff and Mansuy, 2008; Jiang et al., 2008; Sweatt, 2009). 
(We will return to a review of these studies in the following sec-
tion.) DNA methylation, the covalent chemical modiﬁ  cation of 
cytosine side-chains, is another epigenetic mechanism important 
for synaptic plasticity and memory formation. DNA methylation 
occurs in regions of the genome rich in CpG dinucleotides (i.e. 
CpG islands), which are often found in the promoter region of 
genes. The family of enzymes that carry out DNA methylation, 
the DNA methyltranferases (DNMTs), come in two variants, 
maintenance DNMTs including DNMT1 and de novo DNMTs, 
including DNMT3a and 3b. The function of de novo DNMTs is 
to transfer methyl groups to previously unmethylated CpG sites, 
whereas the maintenance DNMTs methylate hemi-methylated 
DNA. DNA methylation has traditionally been associated with 
transcriptional silencing, but there are also instances in which 
DNA methylation can have an activating role (Yasui et al., 2007; 
Chahrour et al., 2008). For example, the presence or addition of 
a methyl group to a stretch of DNA can interefere with the abil-
ity of transcription factors to bind to regulatory elements within 
the DNA sequence, thereby preventing gene transcription from 
occurring. Conversely, there are several molecules that recognize 
and preferentially bind to methylated DNA, including methyl 
CpG-binding domain protein 2 (MeCP2). This activity has the 
potential to either repress or promote gene transcription and may 
depend on whether the regulatory region of the gene is heavily 
methylated or lightly methylated, respectively (Chahrour et al., 
2008; Cohen et al., 2008), suggesting that the methylation status 
of the target gene DNA may ultimately determine whether a gene 
will be transcribed.
The idea that dynamic changes in DNA methylation may con-
tribute to synaptic plasticity and memory function in the adult CNS 
is still a relatively novel one, and as such, a limited number of studies 
have been directed at testing this hypothesis. Work by Levenson 
et al. (2006) was the ﬁ  rst to demonstrate that general inhibitors of 
DNMT activity alter DNA methylation in the adult brain, block 
hippocampal LTP in vitro, and alter the DNA methylation status of 
the plasticity-promoting genes Reln (Reelin) and bdnf. Additional 
studies demonstrated that de novo DNMT expression is upregulated 
in the adult rat hippocampus after contextual fear conditioning and 
that blocking DNMT activity blocked contextual fear conditioning 
(Miller and Sweatt, 2007). In addition, fear conditioning is associ-
ated with rapid methylation and transcriptional silencing of the 
memory suppressor gene Protein Phosphatase 1 (PP1) and demeth-
ylation and transcriptional activation of the synaptic plasticity gene 
Reln. These ﬁ  ndings have the surprising implication that both active 
DNA methylation and active demethylation might be involved in 
long-term memory consolidation in the adult CNS.
More recent work from Sweatt and colleagues has investigated 
the mechanistic interplay between histone acetylation and DNA 
methylation (Miller et al., 2008). Inhibition of DNMT activity 
was found to block histone acetylation, along with memory con-
solidation and LTP, as previously reported (Levenson et al., 2006; 
Miller and Sweatt, 2007). These deﬁ  cits, however, were rescued by 
pharmacologically increasing histone acetylation prior to DNMT 
inhibition. In another recent study on epigenetic regulation of the 
bdnf gene during fear memory formation, it has also been found 
that contextual- fear conditioning evokes differential methylation 
and demethylation of the various bdnf promoters (Lubin et al., 
2008). In animals with a learned fear association, these modiﬁ  ca-
tions are associated with localized histone modiﬁ  cations at speciﬁ  c 
bdnf promoters and upregulation of bdnf transcription (Lubin et al., 
2008). Finally, it has been shown that pharmacologically disrupting 
DNA methylation prevents formation of fear memory (Lubin et al., 
2008). All together, these ﬁ  ndings lend strong support to the idea 
that DNA methylation and histone modiﬁ  cations work together to 
regulate plasticity and memory formation in the adult CNS.
Whether these processes also contribute to the age-related 
changes in synaptic plasticity and memory that have been observed 
in aged, cognitively impaired humans and animal models is the 
focus of on-going studies. For example, work by Siegmund et al. 
(2007) demonstrates signiﬁ  cant increases and decreases in DNA 
methylation within the human brain during both normal and path-
ological aging that corresponds to a concomitant change in mRNA 
levels. In addition, recent work by Penner et al. (2010) demonstrates 
that dynamic DNA methylation of the Arc gene is altered in the 
hippocampus of memory-impaired aged rats compared to adult 
rats. Future studies will be directed at attempts to ameliorate these 
changes in an effort to restore memory function.
A HISTONE CODE IN MEMORY?
The general hypothesis that there is an epigenetic “histone code” 
for memory formation is new and still quite speculative (Chwang 
et al., 2006, 2007; Wood et al., 2006; Borrelli et al., 2008), and 
derives from an earlier idea proposed by Allis and colleagues. The 
overall concept is that multiple post-translational histone modiﬁ  -
cations may be integrated together, combinatorially driving gene 
expression patterns by remodeling the structure of chromatin or 
by recruiting signaling complexes (Jenuwein and Allis, 2001). As 
different histone modiﬁ  cations may be driven by different upstream 
signaling pathways, multiple signals might thus converge on the 
nucleus, controlling gene readout through regulating chromatin 
structure. This would result in a mapping of multiple histone altera-
tion states onto subsets of genes that are transcribed as a result of 
those changes.
Preliminary evidence already exists that supports the idea of a 
histone code for memory. For example, the ERK/MAPK cascade 
has been found to regulate chromatin structure in the hippocam-
pus, and protein kinase MSK1 has been shown to be a mediator 
of the effects of ERK (Chwang et al., 2006, 2007). Interestingly, 
histone H3 phosphorylation at Ser 10 and acetylation at Lys 14, both 
transcriptional activation markers, are signiﬁ  cantly increased with 
fear conditioning training; however, histone H4 acetylation at Lys 
5/8/12/16, also an indicator for activation, is unchanged. Moreover, 
Histone H4 acetylation at those same sites is increased with latent 
inhibition training. At a minimum, these observations show that 
patterns of histone regulation in the hippocampus are speciﬁ  c for 
the type of modiﬁ  cation as well as the residue on which it occurs, 
and can differ with different types of learning. To begin to try to 
explain this complexity of chromatin regulation in memory, we and 
others hypothesized that regulation of histone phosphorylation and Frontiers in Aging Neuroscience  www.frontiersin.org  March  2010 | Volume  2 | Article  9 | 6
Penner et al.  Epigenetics and age-related cognitive dysfunction
acetylation is part of a “histone code” that is read out as a pattern 
of gene transcription speciﬁ  c to different types of hippocampus-
dependent memory (Wood et al., 2006; Borrelli et al., 2008).
Regardless of the validity of the histone code hypothesis, these 
results also support the idea that chromatin acts as a platform for 
signal integration in memory formation (Schreiber and Bernstein, 
2002). Each of the core histones contains N-terminal tails on which 
the majority of histone modiﬁ  cations take place (Peterson and Laniel, 
2004). Each modiﬁ  cation may be targeted by separate, independent 
signaling pathways that converge after reaching the nucleus, and 
chromatin itself may serve as a scaffold on which disparate signals 
are integrated. We and others have shown that phosphorylation 
and acetylation of histone H3 are targeted by ERK and MSK1 in 
hippocampal neurons (Chwang et al., 2007); however, studies in 
cultured embryonic ﬁ  broblasts have also implicated the p38 MAPK, 
SAPK2 and other signal transduction pathways in targeting his-
tone phosphorylation and acetylation (Thomson et al., 1999; see 
Figure 2). Thus, multiple signal transduction pathways may target 
histones independently, and their effects on transcriptional out-
put may be additive, redundant, or even antagonistic. Additional 
work will be needed to determine precisely what other signaling 
pathways may be involved in histone regulation in memory, how 
their relative contributions in histone regulation are integrated to 
produce a coordinated transcriptional output, and whether aging 
results in disruption of baseline chromatin states and alterations 
of memory-associated histone modiﬁ  cation patterns.
MANIPULATING THE EPIGENOME TO IMPROVE MEMORY FUNCTION
The efﬁ  cacy of many transcription factors in modulating tran-
scription depends critically upon the recruitment and activation 
of a number of co-activators of transcription, one example of 
which is the HAT CREB-binding protein (CBP). Thus, regula-
tion of CRE-dependent transcription by CREB depends upon 
the activity of HATs. The effects of HATs are reversed by HDACs 
and by this mechanism HDACs are also critical controllers of 
histone acetylation and transcriptional efﬁ  cacy. In an important 
breakthrough in the last few years several groups discovered that 
broad-spectrum HDAC inhibitors enhance LTP in vitro and aug-
ment memory formation in vivo in normal rodents, in a neuro-
degeneration model, or both (Alarcón et al., 2004; Korzus et al., 
2004; Levenson et al., 2004; Chwang et al., 2006, 2007; Bredy et al., 
2007; Fischer et al., 2007; Lattal et al., 2007; Lubin and Sweatt, 
2007; Miller and Sweatt, 2007; Vecsey et al., 2007; Miller et al., 
2008). These discoveries open up the possibility that HDAC 
inhibitors might be useful clinically in treating aging-related 
memory dysfunction.
To date, there are 11 known HDAC isoforms in the rat (see 
Chuang et al., 2009). A variety of isoform-nonselective and selective 
HDAC inhibitors have been developed (see Table 1), but the unique 
contributions of each of the isoforms in memory formation are just 
beginning to be characterized. Recent work by Guan et al. (2009) 
indicates that HDAC2 overexpression in mice can decrease dendritic 
spine density and synapse numbers, and signiﬁ  cantly interfere with 
both LTP and hippocampal-dependent memory formation. This 
effect is not observed in mice overexpressing HDAC1. In contrast, 
Hdac2-deﬁ  ciency increases synapse number and enhances hippoc-
ampal-dependent memory formation, an effect that closely mimics 
chronic treatment with HDAC inhibitors. In addition, these authors 
found that HDAC2, but not HDAC1 is enriched at several gene pro-
moter regions including Egr1 (as known as zif268), Bdnf, Fos, and 
Creb, suggesting that HDAC2 may suppress the expression of these 
memory-associated genes by binding to their regulatory elements. 
FIGURE 2 | Model for ERK-mediated regulation of histone modiﬁ  cation 
and gene transcription. Activation of NMDA receptors and voltage-gated 
Ca++ channels (VGCC) leads to inﬂ  ux of Ca++ and activation of the ras-MEK-
ERK signaling cascade. This leads to activation of CREB-mediated 
transcription via action of Rsk2 and MSK1. CREB is postulated to facilitate 
transcription through interaction with CREB-binding protein (CBP) and 
acetylation of histones. MeCP2, a methyl-binding domain protein, regulates 
gene activity by binding to methylated CpG dinucleotides. HAT = histone 
acetyltransferase. HMT = histone methyltransferase. MNT-R = modulatory 
neurotransmitter receptors.Frontiers in Aging Neuroscience  www.frontiersin.org  March  2010 | Volume  2 | Article  9 | 7
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Interestingly, the promoter region of the memory-promoting gene 
Arc was predominately associated with HDAC1, suggesting that this 
isoform also regulates the expression of genes necessary for normal 
memory function. Overall, these ﬁ  ndings indicate that HDAC2 
functions as a negative regulator of memory formation, synaptic 
plasticity, and gene expression, while the precise role of HDAC1 in 
memory function remains an open question. Nevertheless, the work 
by Guan et al. (2009) underscores the importance of indentifying 
the relative contributions of speciﬁ  c HDAC isoforms to synaptic 
plasticity and memory function. Moreover, in terms of neurode-
generative and pathological aging, HDAC inhibitors have shown 
some promise ameliorating symptoms in models of Huntington’s 
disease, Parkinson’s disease, stroke, amyotrophic lateral sclerosis, 
spinal muscular atrophy, and Alzheimer’s disease (see Chuang et al., 
2009). One issue that is still of considerable concern is the toxicity 
and side-effects associated with existing HDAC inhibitors, which 
often appear after relatively short-term treatment in cancer patients 
(Bruserud et al., 2007).
Studies of the potential applicability of HDAC inhibitors to 
cognitive aging is at such an early stage that, to our knowledge, 
no studies directly addressing this topic in humans are currently 
available. Thus, speciﬁ  c human studies of clinically available HDAC 
inhibitors (e.g. valproate) have not yet been undertaken. In con-
sidering the potential for these types of studies, it is important 
to keep in mind that valproate and sodium butyrate are non-
 speciﬁ  c inhibitors of HDACs that effect several additional targets 
(e.g., protein kinase C; Manji and Lenox, 1999; Seung Kim et al., 
2001). Clearly, additional selective agents acting at speciﬁ  c HDAC 
isoforms (see Table 1) are needed to begin to address the ques-
tion of the applicability of HDAC inhibitors for therapeutics of 
human cognitive dysfunction. Should improved, isoform-selective 
HDAC inhibitors become available over the next few years, it will 
be interesting to determine their efﬁ  cacy in ameliorating aging-
related memory dysfunction in laboratory animal studies. This is 
not simply a hypothetical consideration, since the development of 
novel isoform-selective HDAC inhibitors is an active area of drug 
development at present.
SUMMARY
In this review, we hypothesize that dysregulation of epigenetic 
control mechanisms and accumulation of aberrant epigenetic 
“marks” (i.e., the chemical additions to DNA and histone proteins) 
are a driver for aging-related cognitive dysfunction. Speciﬁ  cally, 
because transcription of key memory-promoting genes, including 
Arc, zif268 and bdnf, are known to change during aging (Blalock 
et al., 2003; Small et al., 2004; Rowe et al., 2007), we propose that 
these changes are regulated by aberrant epigenetic marks (e.g. DNA 
methylation or histone acetylation, phosphorylation or deacetyla-
tion) and control mechanisms within brain regions particularly 
vulnerable to the aging process (i.e. hippocampus and prefrontal 
cortex), which together result in age-related cognitive deﬁ  cits.
Overall, we feel that our hypothesis will not only fuel new dis-
coveries concerning how memory works at the molecular level, 
but will work in concert with recent ﬁ  ndings from about a dozen 
laboratories illuminating the high potential of using insights gained 
from chromatin molecular biology to design potential new routes 
of therapy for aging-related memory dysfunction. The signiﬁ  cance 
of the hypothesis is 2-fold. One, results will target validation of this 
new approach to alleviate cognitive aging. Two, results will generate 
new insights into whether disruption of chromatin regulation and 
DNA methylation might be a component of the basic molecular 
biology of aging-associated memory dysfunction.
The ideas presented here are also relevant to a broader literature 
concerning a more general epigenetic hypotheses of longevity and 
cellular senescence (Bandyopadhyay and Medrano, 2003; Longo 
and Kennedy, 2006; Blasco, 2007; Fraga and Esteller, 2007; Ramírez 
et al., 2007; Sedivy et al., 2008; Liu et al., 2009). There is an emerging 
understanding that chromatin can be altered in a dynamic way and 
is subject to extensive experience- and age-associated remodeling 
(Bandyopadhyay and Medrano, 2003; Sedivy et al., 2008). Dynamic 
changes in chromatin structure over the lifespan could potentially 
either counter aging and age-associated diseases in some cases, or 
contribute to accelerated aging and age-related dysfunction in other 
cases (Ramírez et al., 2007; Sedivy et al., 2008). For example, global 
loss of DNA methylation in aging or promoter hypermethylation of 
genes with a role in progeria have been proposed to control aging 
and longevity (Fraga and Esteller, 2007). Moreover, the sirtuins, a 
family of NAD-dependent histone deacetylases, are now recognized 
to be a link between chromatin regulation, cellular transformation 
and lifespan (Longo and Kennedy, 2006). Chromatin modiﬁ  cations 
also are now known to be important regulators of mammalian 
telomeres, and the dysfunction of epigenetic regulators such as 
histone methyltransferases and DNA methyltransferases, correlates 
with loss of control of telomere-length control, a mechanism well-
known to contribute to the aging process (Blasco, 2007). Overall, 
a new unifying hypothesis is emerging that suggests that the accu-
mulation of aberrant epigenetic marks, including histone modiﬁ  ca-
tion and DNA methylation and demethylation, may be a driver of 
aging-related cellular and physiologic changes. Here, we propose 
that these ideas be extended to the speciﬁ  c context of aging-related 
memory dysfunction.
FUTURE DIRECTIONS FOR EXPERIMENTATION
There are a number of unanswered questions that remain criti-
cal to understand concerning the potential roles and regulation 
of epigenetic molecular mechanisms in the hippocampus and in 
hippocampus-dependent memory formation in the aging CNS. 
Among these include: (1) Is aging associated with accumulation of 
aberrant epigenetic marks in the hippocampus? (2) Is aging associ-
ated with disruption of memory-associated epigenomic signaling? 
(3) Can one restore normal memory function in the aged CNS 
using pharmacologic agents that manipulate the epigenome? and 
(4) Can one identify a cellular mechanism, speciﬁ  cally disruption 
Table 1 | Classical HDAC isoforms and some examples of their targeted 
HDAC inhibitors.
Classes HDAC  Isoforms  Inhibitors
Class I  HDACs 1, 2, 3, 8  Trichostatin A, Sodium Butyrate, 
   Valproic  Acid,  SAHA
Class II  HDACs 4, 5, 6, 7 , 9, 10  Trichostatin A, Sodium Butyrate, 
   SAHA
Class IV  HDAC 11  SAHA, Trichostatin AFrontiers in Aging Neuroscience  www.frontiersin.org  March  2010 | Volume  2 | Article  9 | 8
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of hippocampal synaptic plasticity, that is a locus for epigenetic 
 disruption of memory with aging? These are four critically impor-
tant areas for future investigation in order to test the hypothesis of 
an epigenetic basis for cognitive aging.
QUESTION 1
Do epigenetic changes at key memory gene loci occurring during 
the aging process? There is a substantial prior literature using rats 
in basic studies of aging-related memory decline, and this model 
system presents a very tractable system for addressing the predic-
tion of the hypothesis that aging should be associated with aberrant 
accumulation of epigenetic marks in memory-associated regions 
of the CNS. Thus, it will be important to compare younger con-
trol animals with both cognitive-healthy aged animals and cogni-
tive-impaired aged animals, and assess whether aging results in 
alterations in CNS DNA methylation, histone modiﬁ  cations, and 
associated changes in memory-driven gene transcription.
QUESTION 2
Is aging associated with disruption of memory-driven epigenetic 
signaling? Previous studies have shown that in younger adult ani-
mals memory formation is associated with (and requires) increased 
gene transcription, altered histone acetylation, and changes in DNA 
methylation. An important prediction of our hypothesis is that aging 
will result in disruption of these speciﬁ  c types of experience-driven 
memory-associated epigenomic signaling mechanisms. These types 
of studies should provide insights into whether aging results in a 
disruption of experience-dependent epigenomic signaling.
QUESTION 3
Can aging-related memory dysfunction be ameliorated by pharma-
cologic intervention that affects epigenetic mechanisms? Currently 
there are several different pharmacologic means of manipulating 
epigenetic mechanisms in the CNS, principally but not exclusively 
through the use of HDAC inhibitors and DNMT inhibitors. One 
compelling experimental course of action at this point is to under-
take preclinical proof-of-principle studies and evaluate if HDAC 
inhibitors can ameliorate the memory and plasticity deﬁ  cits exhib-
ited by aged animals. These are exciting studies that will provide 
an initial validation (or refutation) of the idea of regulation of 
chromatin structure as a “drugable” target for novel therapeutics 
in aging-related cognitive dysfunction. We feel that proceeding 
quickly with the preclinical studies is justiﬁ  ed for several reasons. 
First, the capacity of HDAC inhibitors to augment memory and 
synaptic plasticity is very well-established for a variety of normal 
memory behaviors in animals (Alarcón et al., 2004; Korzus et al., 
2004; Levenson et al., 2004; Chwang et al., 2006, 2007; Bredy et al., 
2007; Lattal et al., 2007; Lubin and Sweatt, 2007; Miller and Sweatt, 
2007; Vecsey et al., 2007; Miller et al., 2008). (112–122). Second, the 
Tsai lab has already demonstrated the efﬁ  cacy of HDAC inhibition 
to improve memory formation in a mouse model with inducible 
neurodegeneration (Fischer et al., 2007). Third, the development of 
new valid targets for therapeutics related to aging-related memory 
dysfunction is a pressing societal and biomedical issue and thus 
must proceed quickly. Finally, the tools and procedures necessary 
to undertake these studies are all in place and routinely used in a 
large number of laboratories interested in aging research.
QUESTION 4
Is disruption of hippocampal LTP a cellular basis for epigenetics-
driven cognitive decline in aging? It is well-documented that aging is 
associated with deﬁ  cits in LTP, a long-lasting form of synaptic poten-
tiation that is strongly implicated as a cellular mechanism underlying 
long-term memory. An important question to address in the future 
is whether pharmacologically manipulating epigenomic signaling 
can restore hippocampal synaptic plasticity in aged animals. These 
studies would provide a strong cellular correlate to the behavioral 
and molecular studies described in Questions 1–3, and also provide 
a speciﬁ  c candidate cellular mechanism for any cognitive improve-
ments that might be observed in response to HDAC inhibition.
CONCLUDING REMARKS
In this article we propose that the dysregulation of epigenetic 
control mechanisms and the accumulation of aberrant epige-
netic marks provide a molecular basis for the cognitive dysfunc-
tion associated with aging. The data demonstrating aberrant gene 
transcription in memory-impaired aged animals was reviewed, as 
well as the data implicating epigenetic regulation of neural plas-
ticity and memory formation. Furthermore, data concerning how 
drugs that can promote or reverse epigenetic changes have been 
highlighted as holding promise for alleviating cognitive dysfunc-
tion. The continued study of epigenetic marks in the regulation 
of cognition promises a future where a viable epigenetic therapy 
treatment may be found that alleviates the growing prevalence of 
memory dysfunction in society.
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